John R DeLoach

Title: **John R. DeLoach: Innovator in Monoclonal Antibody Research**

Introduction

John R. DeLoach is an accomplished inventor based in College Station, Texas, with a remarkable portfolio of 14 patents. His innovative work primarily focuses on the development of monoclonal antibodies and immune cell lines, contributing significantly to advancements in veterinary medicine and immunology.

Latest Patents

Among his notable inventions is a series of patents related to monoclonal antibodies targeting ceftiofur. DeLoach has developed hybridoma cell lines capable of producing monoclonal antibodies that selectively bind to ceftiofur. These hybridomas are created using desfuroyl ceftiofur conjugated to an immunogenic carrier as an immunization agent. The implications of this invention are profound, enabling the detection and quantification of ceftiofur in biological samples by forming an immunocomplex with the antibodies. Additionally, these antibodies can be incorporated into detection kits for ceftiofur quantification.

Another significant patent focuses on a method to produce granulocyte colony-stimulating factor from immortal avian T lymphocyte cell lines. This innovative technique involves recovering T cells from hyperimmunized fowl, exposing them to a mitogen for secondary stimulation, and then virally transforming them to create an immortal cell line. These cell lines are designed to produce and secrete immune lymphokines, which enhance the resistance of fowl to infections when administered.

Career Highlights

Throughout his career, John R. DeLoach has made impactful contributions in the field of immunology, particularly while working with esteemed institutions such as the United States of America, as represented by the Secretary of, and the Texas A&M University System. His work continues to influence the landscape of veterinary medicine.

Collaborations

DeLoach has collaborated with notable colleagues in his field, including Larry H. Stanker and Donald E. Corrier. Together, they have advanced research initiatives that push the boundaries of immunological science and contribute to practical applications in veterinary health.

Conclusion

John R. DeLoach exemplifies the innovation and dedication characteristic of successful inventors. His pioneering work in developing monoclonal antibodies and immune cell lines provides vital tools for the detection of veterinary drugs and enhances the health of animal populations. With a trajectory marked by significant patents and collaborations, DeLoach's contributions continue to echo within the scientific community.